The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): treatment outcome in a single institution cohort.

Treatment of patients with locally recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) is a great challenge. The phase III EXTREME trial demonstrated that the addition of cetu...